The legendary GL Bakris, 700+ papers on PubMed, more importantly, cited almost 250,000 times. Sat at his table a few times during conferences. A delight to listen to what he had to say. Utmost respect. R.I.P. George Bakris

Not sure how high it is, but the incidence of stentgraft edge stenosis in dialysis access is higher that it should be. How to treat them effectively and durably is a hurdle. Here is another case of edge stenosis in #AVF, treated by #FLEX Vessel prep and angioplasty + #DCB 🤞🏻

⁦ASDIN⁩ dinner with a past ASDiN President, huge contributor to IN knowledge base/research and a dear friend! So excited he is volunteering again with ASDIN!

This is probably our hardest goodbye 💔 To our residents: Serving as your chief was the greatest honor of our residency career. We can't thank you enough for this opportunity. We’re beyond excited for the incoming chiefs! #thatsawrap #signingoff🎓 #internalmedicineresidency

On this World Social Media Day, we recognize the power of social media in connecting, communicating, and educating within the field of nephrology. Follow us on X, LinkedIn, Facebook, Instagram, Threads, and WhatsApp for the latest updates, insights, and global stories

Providing fluids is the first thing we do for patients in septic shock. Even though cookie cutter protocols are recommended, we are professionals and better than that. Check out how these legends do it. 🎩 tip to the authors. eddyjoemd.com/foamed/

FASDIN Class of 2025 Application Process is open through July 31, 2024 APPLY TODAY! #FELLOWOFASDIN asdin.org/page/FASDIN

2025 PFS Proposed Rule has been released and is available here: public-inspection.federalregister.gov/2024-14828.pdf

ASDIN encourages our members to participate in RPA Capitol Hill Day on 9/27. Advocacy is critical to all practicing interventionalists and nephrologists so we may continue to provide the best care for our patients. asdin.org/news/677343/Re…

Antibody-mediated rejection is a leading cause of kidney transplant failure. Felzartamab, an IgG1 monoclonal CD38 antibody, is under study for treating antibody-mediated rejection. Research findings are summarized in a new Quick Take video. nej.md/3zJxEEC

ASDIN Launches The Informed Fellow - American Society of Diagnostic and Interventional Nephrology. The Informed Fellow Interventional Nephrology Fast Facts ⁦American Society of Nephrology⁩ ⁦National Kidney Foundation⁩ ⁦RPA-Nephrology⁩ ⁦LSU Health Shreveport Internal Medicine Residency⁩ asdin.org/news/677472/AS…

If you are a #Nephrology Fellow, check this out 👇🏼 📢 The RPA-Nephrology First Look Fellowship for second- or third-year renal fellows will connect you with thought leaders in nephrology, including a mentor from the RPA Board of Directors 👉🏼 APPLY here 👉🏼

📢 Abstract submissions are OPEN for the 21st Annual ASDIN Scientific Meeting! 🔬 Submit by Monday, November 4, 2024. #ASDIN2025 asdin.org/news/679535/AS…

📢Would you like to nominate a peer for an ASDIN Award? NOW IS THE TIME! 2025 Award Nominations are OPEN! asdin.org/news/680212/AS…

We want your feedback! #ASDIN2025 - American Society of Diagnostic and Interventional Nephrology asdin.org/blogpost/11826…

Decision support for PICC Line placement in patients with CKD ca. 2023 #Nephpearls #VascularAccessPearls #VisualGraphic by Brian Rifkin, MD 👉🏼 pubmed.ncbi.nlm.nih.gov/34218708/

Management of the Hemodialysis Patient with Catheter-Related Bloodstream (CRBSI) Infection ca. 2019 from CJASN Crystal Farrington #Nephpearls 👉🏼 pubmed.ncbi.nlm.nih.gov/30837242/

Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) and CKD: Are You a #Flozinator? ca. 2023 from Kidney Medicine GlomCon #Nephpearls 👉 pubmed.ncbi.nlm.nih.gov/36915368/